Matches in SemOpenAlex for { <https://semopenalex.org/work/W2318069845> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2318069845 endingPage "8" @default.
- W2318069845 startingPage "923" @default.
- W2318069845 abstract "The metabolism of 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0437) was investigated in conscious monkeys after subsequent i.v., oral, and ocular administration. The administration of the drug caused some physiological effects, such as bradycardia and sedation of the monkeys. During a collection period of 120 hr, on average 83% was recovered after iv administration and 90% after p.o. dosing. After i.v. administration, 44% was excreted in the bile, as compared to 38% in the urine and about 1% in the feces. After oral administration, bile is the major excretion route, accounting for about 60% of the dose, as compared to 25% in the urine and about 5% in the feces. After ocular administration, on average 62% was recovered after 7 hr, excreted in bile and urine in about equal amounts. All percentages given above reflect the total amount of radioactivity recovered, thus comprising the unchanged drug plus various metabolites. After all three dosing routes, N-0437 was metabolized almost completely prior to elimination. Direct glucuronidation of the phenolic group proved to be the major metabolic pathway of N-0437, comprising about 44% of the dose after i.v. and ocular administration and 72% after oral dosing. Hydroxylation of N-0437 at the position ortho to the phenolic group present yielded a catechol intermediate, which was excreted as a glucuronide and accounted for about 10% of the dose. In the monkey, a clear regioselective preference towards glucuronidation at the 6-position was observed. Besides the glucuronide, the sulfoconjugate of N-0437 was a major metabolite after i.v. and ocular administration, accounting for about 15% of the dose.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W2318069845 created "2016-06-24" @default.
- W2318069845 creator A5008462989 @default.
- W2318069845 creator A5010639861 @default.
- W2318069845 creator A5012502527 @default.
- W2318069845 creator A5063107539 @default.
- W2318069845 creator A5064928364 @default.
- W2318069845 date "1990-11-01" @default.
- W2318069845 modified "2023-09-23" @default.
- W2318069845 title "Metabolism and disposition of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in conscious monkeys after subsequent i.v. oral, and ocular administration." @default.
- W2318069845 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1981538" @default.
- W2318069845 hasPublicationYear "1990" @default.
- W2318069845 type Work @default.
- W2318069845 sameAs 2318069845 @default.
- W2318069845 citedByCount "1" @default.
- W2318069845 crossrefType "journal-article" @default.
- W2318069845 hasAuthorship W2318069845A5008462989 @default.
- W2318069845 hasAuthorship W2318069845A5010639861 @default.
- W2318069845 hasAuthorship W2318069845A5012502527 @default.
- W2318069845 hasAuthorship W2318069845A5063107539 @default.
- W2318069845 hasAuthorship W2318069845A5064928364 @default.
- W2318069845 hasConcept C10146269 @default.
- W2318069845 hasConcept C112705442 @default.
- W2318069845 hasConcept C126322002 @default.
- W2318069845 hasConcept C134018914 @default.
- W2318069845 hasConcept C181199279 @default.
- W2318069845 hasConcept C185592680 @default.
- W2318069845 hasConcept C2777056448 @default.
- W2318069845 hasConcept C2777477808 @default.
- W2318069845 hasConcept C2779186261 @default.
- W2318069845 hasConcept C2779907587 @default.
- W2318069845 hasConcept C2780026642 @default.
- W2318069845 hasConcept C2781109383 @default.
- W2318069845 hasConcept C55493867 @default.
- W2318069845 hasConcept C62231903 @default.
- W2318069845 hasConcept C71924100 @default.
- W2318069845 hasConcept C87644729 @default.
- W2318069845 hasConcept C98274493 @default.
- W2318069845 hasConceptScore W2318069845C10146269 @default.
- W2318069845 hasConceptScore W2318069845C112705442 @default.
- W2318069845 hasConceptScore W2318069845C126322002 @default.
- W2318069845 hasConceptScore W2318069845C134018914 @default.
- W2318069845 hasConceptScore W2318069845C181199279 @default.
- W2318069845 hasConceptScore W2318069845C185592680 @default.
- W2318069845 hasConceptScore W2318069845C2777056448 @default.
- W2318069845 hasConceptScore W2318069845C2777477808 @default.
- W2318069845 hasConceptScore W2318069845C2779186261 @default.
- W2318069845 hasConceptScore W2318069845C2779907587 @default.
- W2318069845 hasConceptScore W2318069845C2780026642 @default.
- W2318069845 hasConceptScore W2318069845C2781109383 @default.
- W2318069845 hasConceptScore W2318069845C55493867 @default.
- W2318069845 hasConceptScore W2318069845C62231903 @default.
- W2318069845 hasConceptScore W2318069845C71924100 @default.
- W2318069845 hasConceptScore W2318069845C87644729 @default.
- W2318069845 hasConceptScore W2318069845C98274493 @default.
- W2318069845 hasIssue "6" @default.
- W2318069845 hasLocation W23180698451 @default.
- W2318069845 hasOpenAccess W2318069845 @default.
- W2318069845 hasPrimaryLocation W23180698451 @default.
- W2318069845 hasRelatedWork W1833208048 @default.
- W2318069845 hasRelatedWork W1983794159 @default.
- W2318069845 hasRelatedWork W2002828889 @default.
- W2318069845 hasRelatedWork W2026851037 @default.
- W2318069845 hasRelatedWork W2066460158 @default.
- W2318069845 hasRelatedWork W2105875857 @default.
- W2318069845 hasRelatedWork W2112091313 @default.
- W2318069845 hasRelatedWork W2333743614 @default.
- W2318069845 hasRelatedWork W2406801323 @default.
- W2318069845 hasRelatedWork W2485882805 @default.
- W2318069845 hasVolume "18" @default.
- W2318069845 isParatext "false" @default.
- W2318069845 isRetracted "false" @default.
- W2318069845 magId "2318069845" @default.
- W2318069845 workType "article" @default.